Sudeep Pharma Share Price
1336.90+44.10 (+3.41%)
+72.69% past 1 Year
Sudeep Pharma along with its subsidiary companies is engaged in business of manufacturing of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and is dedicated to contributing
Corporate filings & documents
Announcements
Submission of Earnings Call Transcript for the call held on 05.08.2026
3 weeks agoSubmission of Earnings Call Transcript for the call held on 05.08.2026
3 weeks agoGeneral Update
4 weeks agoGeneral Update
4 weeks agoSubmission of Audio Recording of Earnings Call held on 05.08.2026
1 month agoSubmission of Audio Recording of Earnings Call held on 05.08.2026
1 month agoSubmission of E-voting and Scrutinizers Report for the 37th Annual General Meeting held on 04.08.2026
1 month agoSubmission of E-voting and Scrutinizers Report for the 37th Annual General Meeting held on 04.08.2026
1 month agoSubmission of newspaper publication of Financials as on 30.06.2026
1 month agoSubmission of newspaper publication of Financials as on 30.06.2026
1 month agoSubmission of revised Investors Presentation
1 month agoSubmission of revised Investors Presentation
1 month agoSubmission of Investors Presentation
1 month agoSubmission of Investors Presentation
1 month agoSubmission of Investors Presentation
1 month agoSubmission of Investors Presentation
1 month agoSubmission of Financials as on 30.06.2026
1 month agoSubmission of Financials as on 30.06.2026
1 month agoSubmission of Outcome of Board Meeting
1 month agoSubmission of Outcome of Board Meeting
1 month agoSubmission of proceedings of the 37th Annual General Meeting held on 4th August 2026
1 month agoSubmission of proceedings of the 37th Annual General Meeting held on 4th August 2026
1 month agoThe Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nuvama Crossover Opportunities Fund Series III & Others
1 month agoThe Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nuvama Crossover Opportunities Fund Series III & Others
1 month agoIntimation for Earnings call to be held on Wednesday 5th August 2026
1 month agoIntimation for Earnings call to be held on Wednesday 5th August 2026
1 month agoSudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve the unaudited financials (standalone & consolidated) for the quarter ended 30th June 2026 and other agenda items.
1 month agoSudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve the unaudited financials (standalone & consolidated) for the quarter ended 30th June 2026 and other agenda items.
1 month agoSubmission of Newspaper Advertisement for 37th AGM E-voting and dividend information published in Business Standard (English) and Vadodara Samachar (regional language) on Saturday 11th July 2026.
1 month agoSubmission of Newspaper Advertisement for 37th AGM E-voting and dividend information published in Business Standard (English) and Vadodara Samachar (regional language) on Saturday 11th July 2026.
1 month agoRecord date for payment of final dividend on equity shares for the FY 2025-26 is Thursday 23rd July 2026.
1 month agoRecord date for payment of final dividend on equity shares for the FY 2025-26 is Thursday 23rd July 2026.
1 month agoLetter to Shareholders in Relation to Integrated Annual Report of the Company for the Financial Year 2025-26
1 month agoLetter to Shareholders in Relation to Integrated Annual Report of the Company for the Financial Year 2025-26
1 month agoSubmission of 37th Annual Report
1 month agoSubmission of 37th Annual Report
1 month agoIntimation for 37th Annual General Meeting to be held on Tuesday 4th August 2026 at 11:00 a.m.
1 month agoIntimation for 37th Annual General Meeting to be held on Tuesday 4th August 2026 at 11:00 a.m.
1 month agoSubmission of Certificate under Regulation 74 (5) of SEBI (DP) Regulations for the Quarter ended 30.06.2026
1 month agoSubmission of Certificate under Regulation 74 (5) of SEBI (DP) Regulations for the Quarter ended 30.06.2026
1 month agoThis is to inform that the Board of Directors at their meeting held on 26th June 2026 has appointed Mr. Milin Mehta as an Additional Director of the Company with immediate effect.
2 months agoThis is to inform that the Board of Directors at their meeting held on 26th June 2026 has appointed Mr. Milin Mehta as an Additional Director of the Company with immediate effect.
2 months agoThis is to inform that the Board has appointed Mr. Milin Mehta as an Additional Director (Non-Executive & Non-Independent) w.e.f. 26.06.2026.
2 months agoThis is to inform that the Board has appointed Mr. Milin Mehta as an Additional Director (Non-Executive & Non-Independent) w.e.f. 26.06.2026.
2 months agoIntimation for Closure of Trading Window w.e.f. 1St July 2026 for Adoption of un-audited Financial Results for the Quarter ended 30th June 2026.
2 months agoIntimation for Closure of Trading Window w.e.f. 1St July 2026 for Adoption of un-audited Financial Results for the Quarter ended 30th June 2026.
2 months agoSubmission of Earnings Call Transcript for Q4 FY26.
3 months agoSubmission of Annual Secretarial Compliance Report for FY 2025-26
3 months agoSubmission of Annual Secretarial Compliance Report for FY 2025-26
3 months agoPursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time we herewith submit the participation of Company Officials in various Investor Conferences in Mumbai as annexed.
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-23
Dividend
1.5
Company details
Registered office
129/1/ A, G. I. D. C. Estate Nandesari Vadodara Gujarat PIN: 391340 Tel No: 0265 2840656 / 7624095107 Fax No: NULL Email: [email protected] Internet: www.sudeepgroup.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Dimple Mehta, Company Secretary & Compliance Officer
Sujit Jaysukh Bhayani, Managing Director
Shanil Sujit Bhayani, Whole Time Director
Ajay Shrirang Kandelkar, Whole Time Director
Milin Mehta, Non Independent & Non Executive Director
Samaresh Parida, Non Executive Independent Director
Raghunandan Sathyanarayan Rao, Non Executive Independent Director
Reshma Patel, Non Executive Independent Director
Sujit Gulati, Non Executive Independent Director
Details
BSE 544619
NSE SUDEEPPHRM
ISIN INE0QPI01025